Trial intelligence / Profile preview

Cold spray versus topical lidocaine spray for pain during intravenous catheter insertion in children

IRCT20170117032025N3Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of lidocaine (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Pain severity. Started Mar 2018; status: completed.

02

Drugs

lidocaine

Beyond the preview

Go deeper on IRCT20170117032025N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170117032025N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call